22-32191125-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001394555.1(RFPL2):āc.784G>Cā(p.Val262Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00073 in 1,613,990 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001394555.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RFPL2 | NM_001394555.1 | c.784G>C | p.Val262Leu | missense_variant | 5/5 | ENST00000652607.2 | NP_001381484.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFPL2 | ENST00000652607.2 | c.784G>C | p.Val262Leu | missense_variant | 5/5 | NM_001394555.1 | ENSP00000498332 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000322 AC: 81AN: 251174Hom.: 0 AF XY: 0.000265 AC XY: 36AN XY: 135742
GnomAD4 exome AF: 0.000772 AC: 1129AN: 1461672Hom.: 2 Cov.: 34 AF XY: 0.000722 AC XY: 525AN XY: 727146
GnomAD4 genome AF: 0.000328 AC: 50AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.784G>C (p.V262L) alteration is located in exon 5 (coding exon 4) of the RFPL2 gene. This alteration results from a G to C substitution at nucleotide position 784, causing the valine (V) at amino acid position 262 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at